Abstract
Objective
Proportion of CIN II/III lesion on cervical biopsy among screen-positive women of age group <40 years and ≥40 years undergoing screening for carcinoma cervix by Pap smear and visual inspection of cervix with acetic acid (VIA) was determined (both the tests were performed on same population). Difference in proportion of CIN II/III lesion among screen-positive women, between two age groups (for both methods) and between methods (for both age groups) was determined.
Result
In <40 years age group, proportion of screen-positive women with CIN II/III lesion was similar for both cytology or VIA (12.95 vs. 9.8%). For ≥40 year age group, compared to cytology, VIA detected higher proportions of CIN II or III lesion (4.1 vs. 13.3%). Proportion of screen-positive women having CIN II/III lesion was higher in <40 years compared to ≥40 year age group (12.95 vs. 4.1%) with cytology, while for VIA no difference was detected in between age groups (9.8 vs. 13.3%).
Conclusion
Cytological screening is less sensitive in women ≥40 years while VIA has a uniform sensitivity for both groups.
Similar content being viewed by others
References
WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and related cancers in india: summary report 2010. Available at http://www.who.int/hpvcentre
Directorate General of Health Services (1984) National Cancer Control Program of India. Government of India, New Delhi
Stjernsward J, Eddy D, Luthra UK, Stanley K (1987) Plotting a new course for cervical cancer in developing countries. World Health Frm 8:42–45
Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM et al (2009) HPV screening for cervical cancer in rural India. N Engl J Med 360(14):1385–1394
Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, Mbalawa CCG, Sharma R, Dolo A, Shastri SS, Nacoulma M, Nayama M, Somanathan T, For the IARC Multicentre Study Group on Cervical Cancer Early Detection (2004) Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer 110:907–913
Sankaranarayanan R, Esmy PO, Rajkumar R (2007) Effect of visual screening on cervical cancer incidence and mortality in Tamilnadu, India: a cluster randomized trial. Lancet 370:398–407
ASC-US-LSIL Triage Study (ALTS) Group (2003) Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 188(6):1383–1392
Saminathan T, Lahoti C, Kannan V, Kline TS (1994) Postmenopausal squamous-cell atypias: a diagnostic challenge. Diagn Cytopathol 11:226–230
Keating JT, Wang HH (2001) Significance of a diagnosis of atypical squamous cells of undetermined significance for papanicolaou smears in perimenopausal and postmenopausal women. Cancer 93(2):100–105
Sankaranarayanan R, Nene BM, Dinshaw KA, Mahe C, Jayant K, Shastri SS, Malvi SG, Chinoy SG, Kelkar R, Budukh AM, Keskar V, Rajeshwarker R, Muwonge R et al on behalf of the Osmanabad District Cervical Screening Study Group (2005) A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer 116:617–623
Arbyn M, Sankaranarayanan R, Muwonge R, Keita N, Dolo A, Mbalawa CG, Nouhou H, Sakande B, Wesley R, Somanathan T, Sharma A, Shastri S, Basu P (2008) Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer 123(1):153–160
Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M et al (2002) The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287(16):2114–2119
Sankaranarayanan R, Wesley R (2003) A practical manual on visual screening for cervical neoplasia: IARC Technical Publication No. 41. Int Agency for Res Cancer, IARC Press, Lyon
Cytryn A, Russomano FB, de Camargo MJ, Zardo LMG, Horta NMSR, de Paula Fonseca RCS et al (2009) Prevalence of cervical intraepithelial neoplasia grades II/III and cervical cancer in patients with cytological diagnosis of atypical squamous cells when high-grade intraepithelial lesions (ASC-H) cannot be ruled out. Sao Paulo Med J 127(5):283–287
Ali PM, Ali SZ (2003) Atypical squamous cell of undetermined significance- rule out high grade squamous intraepithelial lesion: cytopathological characteristics and clinical correlates. Diagn Cytopathol 28(6):308–312
Peto J, Gilham C, Fletcher O, Matthews FE (2004) The cervical cancer epidemic that screening has prevented in the UK. Lancet 364:249–256
Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Møller H, Hakama M, Parkin DM (2005) Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 14(3):677–686
Sankaranarayanan R, Budukh AM, Rajkumar R (2001) Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Org 79:954–962
Sarian LO, Derchain S, Shabalova I, Tatti S, Naud P, Longatto-Filho A, Syrjänen S, Members of the Latin American Screening Study (LAMS), New Independent States of the Former Soviet Union (NIS) Groups (2010) Optional screening strategies for cervical cancer using standalone tests and their combinations among low- and medium-income populations in Latin America and Eastern Europe. J Med Screen 17(4):195–203
Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, Rizzolo R, Schincaglia P, Zorzi M, Zappa M, Segnan N, Cuzick J, New Technologies for Cervical Cancer screening (NTCC) Working Group (2010) Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 11(3):249–257
Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A (2009) Age-specific evaluation of primary human papillomavirus screening versus conventional cytology in a randomized setting. J Natl Cancer Inst 101(23):1612–1623
Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (2007) Human papilloma virus and cervical cancer. Lancet 370:890–907
Cibas ES, Browne TJ, Bassichis MHM, Lee KR (2005) Enlarged squamous cell nuclei in cervical cytologic specimens from perimenopausal women (“PM Cells”) a cause of ASC overdiagnosis. Am J Clin Pathol 124:58–61
Kainz C, Tempfer C, Gitsch G, Heinz H, Reinthaller A, Breitenecker G (1995) Influence of age and human papillomavirus-infection on reliability of cervical cytopathology. Arch Gynecol Obstet 256:23–28
McGrath CM (2002) ASCUS in papanicolaou smears problems, controversies, and potential future directions. Am J Clin Pathol 117(Suppl 1):62–75
Autier P, Coibion M, Huet F, Grivegneel AR (1996) Transformation zone location and intraepithelial neoplasia of the cervix uteri. Br J Cancer 74:488–490
Conflict of interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dasgupta, S., Bhattacharya, S. Is visual inspection with acetic acid better than cervical cytology to screen women ≥40 years of age for carcinoma cervix? A cross-sectional study on proportion of screen-positive women (by VIA and cervical cytology) having CIN II/III lesion on cervical biopsy: difference between two age groups and among screening methods. Arch Gynecol Obstet 285, 1731–1736 (2012). https://doi.org/10.1007/s00404-012-2228-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-012-2228-3